tafluprost

Known as: 1-methylethyl (5Z)-7-((1R,2R, 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy -1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate, Isopropyl (5z)-7-((1R,2R,3R,5S)-2-((1E)-3,3-Difluoro-4-Phenoxybut-1-Enyl)-3,5-Dihydroxycyclopentyl)Hept-5-Enoate 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2018
05101520042018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
AIM To evaluate the ocular surface symptoms and signs associated with preservative-free 0.0015% tafluprost in patients with… (More)
Is this relevant?
2010
2010
PURPOSE The objective of the study was to compare the long-term efficacy and safety of tafluprost 0.0015% with latanoprost 0.005… (More)
Is this relevant?
2010
2010
PURPOSE Tafluprost is a novel prostaglandin F(2alpha)-receptor agonist shown to lower intraocular pressure (IOP) in healthy… (More)
Is this relevant?
2009
2009
To investigate whether tafluprost, which is a prostaglandin-related compound and an anti-glaucoma drug, has a direct anti… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2008
2008
PURPOSE This study compared the toxicity profiles of three antiglaucoma prostaglandin F2alpha analogs, latanoprost, travoprost… (More)
Is this relevant?
2008
2008
PURPOSE Prostanoid F(2alpha) (PF(2alpha)) analogues are commonly used as first-line treatment of glaucoma. Tafluprost is a newly… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2008
2008
PURPOSE The aim of this study was to determine the short-term effects of topical tafluprost, a novel prostaglandin F(2… (More)
Is this relevant?
2007
2007
OBJECTIVE The aim of this study was to determine the safety, tolerability, and pharmaco-dynamics of a novel prostanoid… (More)
Is this relevant?
2005
2005
PURPOSE To establish a mouse model for the pharmacological analysis of antiglaucoma drugs, considering the effect of variations… (More)
Is this relevant?
2004
2004
To evaluate the pharmacological characteristics of AFP-168 (tafluprost), a new prostaglandin (PG) F(2alpha) derivative, we… (More)
Is this relevant?